Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 99151
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.99151
Table 1 General data and laboratory test indicators, mean ± SD/n (%)
Characteristic
Control group (n = 48)
Observation group (n = 55)
χ2/t value
P value
Age (years)61.21 ± 10.2165.20 ± 9.962.0060.048
Sex0.1730.677
Male29 (60.42)31 (56.36)
Female19 (39.58)24 (43.64)
History of smoking and drinking0.1090.741
With26 (54.17)28 (50.91)
Without22 (45.83)27 (49.09)
Family history of coronary heart disease2.7460.098
With15 (31.25)26 (47.27)
Without33 (68.75)29 (52.73)
BMI (mmol/L)23.15 ± 2.6924.09 ± 2.741.7520.083
FBG (mmol/L)10.58 ± 2.8714.72 ± 3.926.0380.000
TG (mmol/L)2.09 ± 0.792.41 ± 0.822.0150.047
TC (mmol/L)5.82 ± 1.086.18 ± 1.121.6550.101
HDL-C (mmol/L)1.13 ± 0.521.24 ± 0.481.1160.267
LDL-C (mmol/L)2.98 ± 0.573.22 ± 0.632.0170.046
SCr (μmol/L)62.77 ± 10.8763.76 ± 11.250.4530.652
BUN (mmol/L)5.49 ± 1.146.05 ± 1.582.0350.044
ALT (U/L)25.88 ± 5.9227.71 ± 6.311.5110.134
AST (U/L)24.72 ± 6.7425.41 ± 6.170.5420.589
Table 2 Comparison of coronary imaging characteristics between control and observation group, n (%)
Characteristic
Control group (n = 48)
Observation group (n = 55)
χ2 value
P value
Diffuse lesion15.4200.000
With12 (25.00)35 (63.64)
Without36 (75.00)20 (36.36)
Degree of stenosis6.3990.041
Moderate24 (50.00)15 (27.27)
Severe13 (27.08)17 (30.91)
Occlusion11 (22.92)23 (41.82)
Table 3 Comparison of stenosis index between control and observation group, mean ± SD
Characteristic
Control group (n = 48)
Observation group (n = 55)
t value
P value
RCA stenosis index2.57 ± 1.073.98 ± 1.056.7300.000
LCX stenosis index2.09 ± 1.123.37 ± 1.145.7380.000
LAD stenosis index3.38 ± 1.323.59 ± 1.080.8900.376
LMT stenosis index1.05 ± 0.410.97 ± 0.331.0960.275
Total stenosis index9.09 ± 2.1211.91 ± 1.947.0490.000
Table 4 Comparison of coronary imaging characteristics in males and females, n (%)
Characteristic
Male (n = 60)
Female (n = 43)
χ2 value
P value
Diffuse lesion1.8370.175
With24 (40.00)23 (53.49)
Without36 (60.00)20 (46.51)
Degree of stenosis2.8980.235
Moderate23 (38.33)16 (37.21)
Severe14 (23.33)16 (37.21)
Occlusion23 (38.33)11 (25.58)
Table 5 Comparison of stenosis index in males and females, mean ± SD
Characteristic
Male (n = 60)
Female (n = 43)
t value
P value
RCA stenosis index3.28 ± 1.313.39 ± 1.220.4320.666
LCX stenosis index2.91 ± 1.312.59 ± 1.271.2380.219
LAD stenosis index3.45 ± 1.133.55 ± 1.290.4170.677
LMT stenosis index1.01 ± 0.361.00 ± 0.390.1340.894
Total stenosis index10.64 ± 2.4810.53 ± 2.470.2220.825
Table 6 Comparison of hypoglycemic treatment history and glycosylated hemoglobin levels between control and observation group, n (%)
Characteristic
Control group (n = 48)
Observation group (n = 55)
χ2 value
P value
Metformin treatment5.0730.024
With29 (60.42)21 (38.18)
Without19 (39.58)34 (61.82)
HbA1c6.9800.008
> 7.0%13 (27.08)29 (52.73)
≤ 7.0%35 (72.92)26 (47.27)
Table 7 Univariate logistic regression analysis
Characteristic
B
SE
Wals
df
OR
95%CI
P value
Age0.0400.0213.80711.0411.000-1.0840.051
FBG0.3680.08120.41811.4441.231-1.6940.000
TG0.5060.2593.82611.6580.999-2.7520.050
LDL-C0.6730.3433.85311.9591.001-3.8350.050
BUN0.2940.1483.92611.3421.003-1.7940.048
Metformin (with vs without)-0.9050.4054.98910.4050.183-0.8950.026
HbA1c (> 7.0% vs ≤ 7.0%)1.1000.4226.77613.0031.312-6.8720.009
Table 8 Multivariate logistic analysis
Characteristic
B
SE
Wals
df
OR
95%CI
P value
FBG0.3860.09018.53311.4721.234-1.7550.000
BUN0.3110.1852.82411.3650.950-1.9630.093
Metformin (with vs without)-1.0500.5104.23110.3500.129-0.9520.040
HbA1c (> 7.0% vs ≤ 7.0%)1.1620.5224.95313.1971.149-8.8960.026